Due to its crucial role in inflammation, IL-1 is increasingly considered as an attractive therapeutic target for a broad spectrum of diseases, such as autoimmune and autoinflammatory diseases, infections, metabolic disorders, ischemic conditions, and malignant tumors [66]. Here, IL1B is linked to metabolic disease.